Sandoz acquires CIMERLI® business from Coherus, further building biosimilar and ophthalmology leadership in US market.

Linked as:


Document options

Extract

Sandoz acquires CIMERLI® business from Coherus, further building biosimilar and ophthalmology leadership in US market.

No longer available (Autolink)

See the full content of this document